LY6K and breast carcinoma: The activation of TGF‐β and EGF signaling pathways plays a critical role in cancer metastasis and proliferation, respectively, where LY6K is required for TGF‐β‐ and EGF‐induced metastasis in breast cancer and glioblastoma.11, 12